We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00512811
First Posted: August 8, 2007
Last Update Posted: August 8, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Baqiyatallah Medical Sciences University
August 7, 2007
August 8, 2007
August 8, 2007
Not Provided
Not Provided
effect of furosemid inhalation on dyspnea
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients
Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study
to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure
Not Provided
Interventional
Phase 3
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Bronchiolitis
Drug: furosemide
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Patients with a history of exposure to sulfur mustard with a complaint of dyspnea

Exclusion Criteria:

  • A contraindication for furosemide use;
  • An accompanying disease in which other drugs effective for dyspnea were used
Sexes Eligible for Study: Male
32 Years to 83 Years   (Adult, Senior)
Not Provided
Contact information is only displayed when the study is recruiting subjects
Iran, Islamic Republic of
 
 
NCT00512811
121a25
Yes
Not Provided
Not Provided
Not Provided
Baqiyatallah Medical Sciences University
Not Provided
Study Chair: Mostafa Ghanei, MD Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran
Baqiyatallah Medical Sciences University
August 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP